Schneider Shorts 8.05.2026 – Incredible Future Is Now Becoming Reality
The biotech sector faced a series of high‑profile setbacks in early May 2026. Amgen was forced to withdraw its drug avacopan after the FDA uncovered fabricated trial data, a scandal tied to a $4 billion acquisition of ChemoCentryx. Russia announced a $26 billion state‑backed anti‑aging program targeting the RAGE gene, while the founder of Human Longevity, Craig Venter, died after self‑treating prostate cancer. Simultaneously, multiple papers were retracted following whistleblower revelations and an AI‑generated image in NEJM was withdrawn.
Mansoor Amiji: Rare Gem and Modern-Day Polymath
Mansoor Amiji, a Tanzanian‑born nanomedicine researcher, was named a Fellow of the National Academy of Inventors in December 2025, recognizing three decades of vaccine and drug‑delivery innovations. Simultaneously, a deep‑dive review reveals 31 of his publications flagged on PubPeer for image...